4//SEC Filing
Wiley Matthew T. 4
Accession 0001209191-21-013821
CIK 0001566044other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:40 PM ET
Size
7.5 KB
Accession
0001209191-21-013821
Insider Transaction Report
Form 4
Wiley Matthew T.
Chief Commercial Officer
Transactions
- Award
Stock Options
2021-02-22+64,575→ 64,575 totalExercise: $8.33Exp: 2031-02-22→ Common Stock (64,575 underlying) - Award
Common Stock
2021-02-22+27,675→ 116,970 total
Footnotes (2)
- [F1]Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc.
- [F2]The awards vest over four years, 25% on March 31, 2022 and 6.25% every three months thereafter, ending on March 31, 2025.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001759703
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:40 PM ET
- Size
- 7.5 KB